Monosodium benzoate hypersensitivity in subjects with persistent rhinitis by Pacor, M. et al.
Original article
Monosodium benzoate hypersensitivity in subjects with
persistent rhinitis
It is estimated that 2–4% of the general population suﬀers
from chronic nasal disease with daily symptoms and need
for medication (1). Around 30–70% of these subjects
show a so-called ‘idiopathic’ rhinitis (1, 2), for it is deﬁned
as rhinitis with no proven immunological, microbiologi-
cal, pharmacological, hormonal, or occupational causes
(1, 3–5). Among the possible causes of these ‘idiopathic’
cases of rhinitis, drugs and food additives have been
frequently acknowledged (6, 7). A range of allergic-like
symptoms can follow the ingestion of sulphite, tartra-
zine, monosodium glutamate, monosodium benzoate,
p-hydroxybenzoate, and erythrosine (8–11). Reactions
to these compounds cannot be distinguished, clinically,
from an IgE-mediated rhinitis. More commonly, the daily
consumption of food additives leads to continuous and
protracted symptoms that mimic allergic phenomena (11).
Background: Very few data are available from the literature on whether nona-
topic subjects aﬀected by persistent rhinitis may show the appearance of
objective symptoms of rhinitis after the ingestion of food additives such
as tartrazine (E102), erythrosine (E127), monosodium benzoate (E211),
p-hydroxybenzoate (E218), sodium metabisulphite (E223), and monosodium
glutamate (E620). It is still unclear whether the ingestion of food additive
may cause, as well, a consensual reduction of nasal peak inspiratory ﬂow
(NPIFR). Therefore, we used a double-blind placebo-controlled (DBPC)
study to evaluate this hypothesis.
Patients and methods: Two hundred and twenty-six consecutive patients (76
males and 150 females) aged 12–60 years (mean age 40.2 ± 16.3 years). After
1 month of an additive-free diet regimen, an open challenge was carried out
(food additive-rich diet for 2 weeks). After this period, challenges were admin-
istered in a DBPC manner using the above-mentioned substances under inves-
tigation.
Results: Twenty of 226 subjects (8.8%) reported an improvement of the symp-
toms of rhinitis after additive-free diet. More precisely, six of 226 (2.6%) were
symptom-free and 14 of 226 (6.2%) showed an improvement in their symptoms
after an additive-free diet. As far as the results for DBPC are concerned, 20
challenges with monosodium benzoate induced both objective (i.e. sneezing and
rhinorrhoea) and subjective symptoms (nasal blockage and nasal itching) of
rhinitis with reduction of NPIFR ‡20%, 45 challenges induced subjective
symptoms of rhinitis (i.e. nasal blockage and nasal itching), without reduction
of NPIFR ‡20% of the basal value, two with tartrazine, seven with
erythrosine, 19 with monosodium benzoate, three with p-hydroxybenzoate,
six with sodium metabisulphite, and eight with monosodium glutamate,
respectively.
Conclusions: The observation that nonatopic persistent rhinitis may be caused
by the frequent, probably daily, ingestion of small doses of a nontolerated
substance is intriguing and suggests that at least some patients with ‘chronic
vasomotor rhinitis’ may be intolerant to a particular food additive. Therefore,
food additives can be considered triggers or aggravating factors, rather than
aetiological factors.
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While these symptoms occur by activating biochemical
pathways that mediate inﬂammation (12), IgE speciﬁc for
the triggering agents are not involved. These unusual
reactions to chemical additives can be attributed to
hypersensitivity (13). Previously, these reactions were
called idiosyncratic or pseudo-allergic reactions (11–13).
The symptoms that characterize nonallergic rhinitis are
usually similar to those occurring in persistent allergic
rhinitis, with the exception of eye symptoms that are less
frequent whereas nasal blockage is more prominent. Such
symptoms are often precipitated by nonspeciﬁc stimuli,
such as cigarette smoking, strong odours, perfumes,
alcoholic beverages, cold air, and hot spicy food (1).
From a chemical and functional perspective, food
additives are a heterogeneous group of substances
including preservatives, such as antimicrobials and
antioxidants, dyes, emulsiﬁers, stabilizers, and sweeten-
ers. Their consumption is a matter of public concern and
debate, particularly because they may cause a number of
illnesses. However, there is a great discrepancy between
the subjective perception of hypersensitivity to food
additives and the results of objective diagnostic tests
(1, 14–16). If hypersensitivity to food additives is
suspected, the only method to prove this hypothesis is
to test it by a double-blind placebo controlled (DBPC)
challenge test (14, 15).
The objective of this study was to evaluate the
prevalence of hypersensitivity to additives in a group of
subjects aﬀected by persistent rhinitis. We examined the
results obtained after a period of diet, without and with
food additives, on daily symptoms and we also evaluated
the results of DBPC with six food additives in the same
subjects.
Patients and methods
Patients
Two hundred twenty-six patients (76 males and 150 females) aged
between 12 and 60 years (mean age 40.2 ± 16.3 years), who
referred to the Outpatients Allergy Unit of the Policlinico GB Rossi
of Verona Italy, were enrolled in the study. All patients were
aﬀected by persistent rhinitis. Written informed consent was
obtained from each participant, and the Institutional Review Board
of the Department of Internal Medicine, University of Verona,
Italy, approved the study, that was conducted according to the
Declaration of Helsinki of 1975.
Subjects were evaluated by an allergist physician and by a dietician
previous to admission to the study.None of the subjects suﬀered from
other clinically signiﬁcant diseases besides persistent rhinitis. Rhinitis
was classiﬁed as persistent andmoderate–severe, based on the clinical
history and symptoms (present formore than 4 days aweek andmore
than 4 weeks) (1, 17).
All subjects ﬁlled in a respiratory questionnaire based on the
standardized Clinical European Community Respiratory Health
Survey, which is a structured questionnaire aimed at evaluating the
presence of asthma symptoms (18). No subject had history, or
symptoms, of asthma.
None of the subjects was taking oral steroids during the study;
neither had they been taking them during the 2 months previous to
enrolment in the study. Patients underwent therapy for the symp-
toms of rhinitis with diﬀerent antihistamines and/or with vasocon-
strictors, with partial improvement. None of the women
participating in the study was pregnant nor breastfeeding the child
during the study. Only patients fulﬁlling all the criteria reported in
Table 1 were considered eligible for the study.
Study design
All patients visited the clinic four times (at time 0, 7, 30, and
45 days) before undergoing the DBPC. At visit 1 patients were given
a daily diary card of symptoms and were informed of the purpose of
the study. All patients were asked to ﬁll in a daily clinical diary (see
Assessment of the symptoms of rhinitis). At visit 2, 7 days later, the
daily diary cards were checked carefully and then the patients
started the additive-free diet. At visit 3, 30 days later, the daily diary
cards were checked again and patients with an improvement in
rhinitis symptoms during the food additive-free diet started an open
challenge with a food additive-rich diet. At visit 4, 15 days later, the
daily diary cards were checked for the last time. Finally, all patients
underwent the DBPCs (Fig. 1).
Assessment of the symptoms of rhinitis
Before and during the periods of diet, each patient recorded
symptom scores in a daily diary card. Patients reported nasal
blockage, sneezing, rhinorrhoea, and nasal itching that were rated
on an arbitrary four-point rating scale, from 0 to 3 (0 ¼ absent,
1 ¼ mild, 2 ¼ moderate, and 3 ¼ severe). Therefore, the scores of
total symptoms ranged from 0 to 12 and represented the sum of the
scores referring to the presence of nasal blockage, nasal itching,
sneezing, and rhinorrhoea.
Elimination diet (without food additives) and open challenges
An elimination additive-free diet was started (14–16) by all patients.
After 1 month of additive-free diet, during which 20 patients
showed an improvement in their rhinitis symptoms, an open chal-
Table 1. Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Long-lasting (>6 months) rhinitis including nasal blockage, watery rhinorrhoea,
itching of the nasal mucosa, and episodes of sneezing paroxysm
Positive skin prick test results with the common airborne allergens, including pollen
(grass, mugwort, ragweed, olive, birch, cypress, parietaria, and plantain), mites, moulds
(Alternaria, Aspergillus, and Cladosporium) and dander of cat and dog and foods
Diagnosis of rhinitis in the absence of both structural deformities and nasal
polyps on ear, nose, and throat investigation
Smoker or exsmoker subjects
Normal plain radiograph film and/or computed tomography scan Patients who had used intranasal corticosteroids, antihistamines, and vasoconstrictors
in the preceding 2 weeks
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lenge with a food additive-rich diet was carried out. After 3 days,
nasal symptoms relapsed and/or worsened progressively in these
patients, lasting throughout the whole open-challenge period.
Table 2 reports the food excluded and included during the food
additive-free diet and food additive-rich diet, respectively.
Food additive challenges
The chemicals which have been tested and the doses are reported
in Table 3. A food additive oral challenge was performed. The
food additives and placebo were in gelatine capsules. For each of
the six chemicals, pharmacists, who ensured that placebo and
substances were all similar, prepared a speciﬁc set with diﬀerent
doses. The subjects, the doctor, and the ambulatory assistants were
all blinded to the contents of the challenge. The food chemical
challenge was performed under the supervision of the doctor.
Bronchodilators, adrenaline and resuscitation equipment were
available all the time for the treatment of any acute eﬀect caused
by the challenges from additives. A food additive at a time was
used for the challenge. Each substance under investigation was
tested at an interval of at least 1 week. Challenges were adminis-
tered in a DBPC fashion during the morning hours. Before each
DBPC, patients received a sham challenge with placebo (talc).
When no symptoms had been noted after the sham challenge,
DBPC was performed 1 h later using either placebo or the sub-
stance under investigation. The substances and the placebo were
given in a randomized sequence. Three placebo capsules and three
doses of the substance under investigation were given at the dos-
ages reported in Table 3. Each dose was given at intervals of 3 h, if
no symptoms had developed during the previous administration.
Both objective and subjective symptoms were carefully recorded
after each dose (see Evaluation of DBPC).
Nasal peak inspiratory flow measurement
Nasal peak inspiratory ﬂow (NPIFR) of all patients was measured
before, during and after the oral additive food challenge, using a
portable inspiratory ﬂow meter (Clement Clarke International Ltd,
Edinburgh, UK), with a proper face mask. Before testing, patients
were advised toblow their noses to expel secretions.Allmeasurements
were made in a sit down position, with a good seal round the face
mask, and patients were forced to inspire from the residual volume
to total lung capacity through their nose,with theirmouth closed (19).
Evaluation of DBPC
The results of the test for each substance were evaluated and cor-
related with the available case history information. The results of
the challenge test were considered ‘positive’ when the patients
developed rhinitis symptoms (i.e. nasal blockage, sneezing, and
rhinorrhoea) with a fall of NPIFR by at least 20% from the
postsham challenge. The provocation results were designated as
‘probably negative’ if subjective symptoms (i.e. nasal blockage
without other symptoms of rhinitis) were present, without signiﬁ-
cant reductions of NPIFR; as ‘negative’ when the patients had
neither objective nor subjective changes.
Statistical analysis
Age of patients has been presented as mean ± SD. Symptom
scores were evaluated as total symptom score (TSS), (the sum of
individual symptoms). The TSS during the run-in period, additive-
free diet and open challenge were expressed as median (the range
minimum and maximum). Nonparametric statistics was used for
analysis. We used a Kruskal–Wallis test, as ﬁrst analysis. If sig-
niﬁcant changes were detected, a posthoc analysis was performed
by use of the Wilcoxon signed rank test. P £ 0.05 was considered
statistically signiﬁcant.
Additive free diet
(30 days)
Open challenge
Free diet
(15 days)
DBPC with food additives
Symptom scores
Anterior rhinoscopy
NPIFR
Evaluation of
rhinitis symptoms
(7 days)
Visit 1
Visit 2
Visit 3
Visit 4
Symptom scores
(daily diary card)
Symptom scores
(daily diary card)
Symptom scores
(daily diary card)
Subjects affected by perennial rhinitis
(no. 226)
Figure 1. Study design.
Table 2. Food additive-rich*
Breakfast
Muesli, dried apricots (containing sulphites), yoghurt, margarine (containing
preservatives), honey, and jam (containing preservatives)
Lunch and dinner
Instant broth (containing glutamate), spaghetti with tomato in box (containing
preservatives); potato salad (containing benzoic acid), fish salad (containing
benzoic acid), matured cheese (containing preservatives) ham (containing
preservatives), burger; olives (containing colouring), seasoning: paprika, thyme,
oregano, pepper, nutmeg, oil, vinegar, garlic, onion; fruit jelly (containing
colouring agents), apple, blueberries/strawberries (fresh or frozen) (containing
benzoic acid)
Drink
Coffee, tea, chocolate bar, fizzy drinks (containing benzoic acid and colouring agents)
* The diet was explained and personalized to the patients by a dietician.
Table 3. Doses (mg) used for double-blind placebo-controlled challenges
Substances under investigation
First
dose
Second
dose
Third
dose
Low
dose
High
dose
Tartrazine (E102) 10 10 20 10 40
Erythrosine (E127) 50 50 100 50 200
Monosodium benzoate (E211) 50 50 100 50 200
p-Hydroxybenzoate (E218) 50 50 100 50 200
Sodium metabisulphite (E223) 5 5 10 5 20
Monosodium glutamate (E620) 100 100 200 100 400
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Results
All the enrolled patients completed the study. Twenty of
226 patients showed an improvement in their symptoms
while on diet, whereas 206 patients did not. Particularly,
six of 226 (2.6%) were symptom-free and 14 of 226
(6.2%) showed an improvement in their symptoms.
Daily score of symptoms of rhinitis during pre-DBPC periods
In the group with amelioration (20 subjects), the
median of the rhinitis symptom score before the
additive-free diet was 8.5 (range 2–12) and decrease
signiﬁcantly after diet to 2.5 (range 0–4) (P < 0.05). In
the nonresponder group (206 subjects) no signiﬁcant
change of rhinitis symptom score nor even a worsening
of symptoms was observed: the median value before the
diet was 8.0 (range 2–12) and after diet 8.5 (range 3–12)
(P ¼ NS). In the group in which the subjects improved
their symptoms to additive-free diet, during the open
challenge with additive-rich diet, the median of the
rhinitis symptom score 7.5 (range 5–12) was higher
compared with the median of the period of the
additive-free diet 2.5 (range 0–4) (P < 0.05), whereas
we found no diﬀerences between the period before the
additive-free diet and the open challenge period
(P ¼ NS).
Challenge
Double-blind placebo-controlled trials were performed in
all patients, improved and unimproved to additive-free
diet. The group without amelioration was used as the
control group to DBPC. We performed a total of 9452
challenges. This number is the sum of all the following
tests: 1356 [226 of patients tested and six of placebo used
for the sham challenge (basal values of NPIFR), plus
4048 (number of capsules of placebo used for DBPC),
plus 4048 (number of capsules of food additives used for
DBPC].
All data reported below have been calculated with
reference to the total number of capsules of food additive
used for DBPC (4048). With respect to DBPC-induced
rhinitis, 20 challenges (0.5%) were considered as ‘posit-
ive’, because the patients presented objective and sub-
jective symptoms of rhinitis with a reduction of NPIFR
‡20% from the basal value. Forty-ﬁve challenges (1.1%)
were considered as ‘probably negative’, because the
patients referred only nasal blockage but without fall of
NPIFR ‡20% of the basal value and without other
objective symptoms of rhinitis. Finally, 3983 challenges
(98.4%) were considered as ‘negative’ because neither
objective nor subjective symptoms of rhinitis were
observed (Table 4).
As regards dose-inducing rhinitis, the DBPCs with
monosodium benzoate at a dose of 100 mg gave a
positive reaction in 20 patients. The other reactions,
induced to DBPCs, were considered as ‘probably negat-
ive’: tartrazine in two patients at the dose of 40 mg,
erythrosine in seven patients at the dose of 200 mg,
monosodium benzoate in 19 patients at the dose of
200 mg, p-hydroxybenzoate in three patients at the dose
of 200 mg, sodium metabisulphite in six patients at the
dose of 20 mg, and ﬁnally monosodium glutamate in
eight patients at the dose of 400 mg.
Repeated challenge tests were performed in all patients
with reactions considered ‘positive’, and ‘probably neg-
ative’, but no changes occurred.
Discussion
In this study 20 of 226 patients (8.8%) suﬀering from
persistent rhinitis reacted to monosodium benzoate, with
typical symptoms of rhinitis, proved by a DBPC additive
challenge, with a reduction in NPIFR by at least 20%,
after sham challenge. The same patients showed an
amelioration of their rhinitis symptoms with an additive-
free diet. More precisely, six of 226 (2.6%) were symp-
tom-free and 14 of 226 (6.2%) showed an improvement in
Table 4. Results of DBPC with regard to symptoms of rhinitis
Substance
Symptoms of rhinitis with
reduction of NPIFR ‡20%
of basal value (P)
Subjective symptoms of
rhinitis without reduction of
NPIFR ‡20% of basal value (PN) No symptoms of rhinitis (N)
No. of total testsn (%) n (%) n (%)
Placebo 0 (0) 0 (0) 5404 (100) 5404*
E102 0 (0) 2 (0.3) 676 (99.7) 678
E127 0 (0) 7 (1.0) 671 (99.0) 678
E211 20 (3.0) 19 (2.9) 619 (94.1) 658
E218 0 (0) 3 (0.5) 675 (99.5) 678
E223 0 (0) 6 (0.9) 672 (99.1) 678
E620 0 (0) 8 (1.2) 670 (98.8) 678
Total additives 20 (0.5) 45 (1.1) 3983 (98.4) 4048
P, positive response for rhinitis; PN, probably negative response for rhinitis; N, negative response for rhinitis.
* Total number of placebo capsules used for challenges.
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their symptoms. This is the ﬁrst controlled clinical trial
that demonstrates the possible role of food additives in
persistent rhinitis.
Rhinitis is a symptomatic disorder characterized by
rhinorrhoea, nasal blockage, sneezing, and nasal itching
(1, 2, 4). After the exclusion of common cold, rhinitis can
be classiﬁed either as allergic or nonallergic, noninfec-
tious (1). The last category of rhinitis usually includes
rhinitis of both known and unknown origins (1, 20).
A number of studies claiming that food additives are
responsible for an array of clinical conditions, including
urticaria, angio-oedema, anaphylaxis, asthma, chronic
fatigue syndrome, irritable bowel syndrome, headache,
collagen and vascular diseases, and even behavioural
disturbances, have appeared in the medical literature
(6, 7, 9, 13, 14, 21–27).
The prevalence of adverse reactions to food additives
is reported in two population-based studies. In a Danish
study in schoolchildren, 6.6% perceived adverse reaction
to food additives and 2% developed adverse reactions to
a mixture of food colourings, preservatives, and ﬂa-
vours. The main symptoms were aggravation of atopic
dermatitis or urticaria. One per cent reacted to DBPC
challenge, with a mixture of colourings or preservatives
in capsules (26). In a UK population study including
children and adults, 7.4% of subjects reported adverse
reactions caused by food additives. In that study three
subjects had a positive challenge to groups of food
additives, i.e. colourings, preservatives, and antioxidants.
The symptoms were headache, upper abdominal pain,
eczema, and mood swings. The prevalence of food
additive intolerance was 0.026% (27). The great vari-
ation in prevalence estimates of the two studies reﬂects
the diﬃculty of studying adverse reactions to a large
group of substances, such as food additives. It also
reﬂects the heterogeneity of the populations included in
such studies. On the contrary, the subjects in our study
were aﬀected only by persistent rhinitis and none was
atopic or allergic.
Therefore, few data are presented in the literature
about the relationship between rhinitis and food addi-
tives. To address the relationship between rhinitis and
food additive, we performed a comprehensive literature
search from 1965 to December 2002 using MEDLINE
database and a manual research on Allergy, ENT, and
pulmonary-specialized journals. We found only three case
reports on the relationship between rhinitis and food
additive, and 13 reviews, mostly anecdotal reports,
heavily biased by the lack of appropriate diagnostic
procedures. Asero described three case reports (28–30).
The ﬁrst case is of chronic rhinitis caused by intolerance
to sodium benzoate diagnosed by rigorously controlled
methods (28). The second case is of multiple intolerance
to food additives causing both persistent rhinitis and
worsening of chronic urticaria (29). The third case is of
nonatopic persistent rhinitis caused by intolerance to
benzoate (30).
A reaction of intolerance means that the ingestion of
additives with foods is the cause of the disease and that
the elimination of these additives from ingested foods
should lead to complete clearance of symptoms. Relapses
may occur after the re-introduction of the additives. In
our study, only six of 226 patients, after the additive-free
diet, demonstrated a complete remission and 14 of 226 an
improvement of the rhinitis symptoms. The data of
additive-free diet and additive-rich diet demonstrate that
food additives could be triggers or aggravating factors,
rather than aetiological factors. These results could
explain why food additives provoke an exacerbation of
an existing chronic disease, such as persistent rhinitis.
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